157 related articles for article (PubMed ID: 30375926)
41. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of a Rapid Lumbar Spine MRI Protocol Using 3D T2-Weighted SPACE Imaging Versus a Standard Protocol for Evaluation of Degenerative Changes of the Lumbar Spine.
Sayah A; Jay AK; Toaff JS; Makariou EV; Berkowitz F
AJR Am J Roentgenol; 2016 Sep; 207(3):614-20. PubMed ID: 27275868
[TBL] [Abstract][Full Text] [Related]
43. Detection of clinically occult primary tumours in patients with cervical metastases of unknown primary tumours: comparison of three-dimensional THRIVE MRI, two-dimensional spin-echo MRI, and contrast-enhanced CT.
Yoo MG; Kim J; Bae S; Ahn SS; Ahn SJ; Koh YW
Clin Radiol; 2018 Apr; 73(4):410.e9-410.e15. PubMed ID: 29195660
[TBL] [Abstract][Full Text] [Related]
44. Which MRI sequence of the spine best reveals bone-marrow metastases of neuroblastoma?
Meyer JS; Siegel MJ; Farooqui SO; Jaramillo D; Fletcher BD; Hoffer FA
Pediatr Radiol; 2005 Aug; 35(8):778-85. PubMed ID: 15883828
[TBL] [Abstract][Full Text] [Related]
45. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.
Seemann MD; Meisetschlaeger G; Gaa J; Rummeny EJ
Eur J Med Res; 2006 Feb; 11(2):58-65. PubMed ID: 16504962
[TBL] [Abstract][Full Text] [Related]
46. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
[TBL] [Abstract][Full Text] [Related]
47. Differentiation of Vertebral Metastases From Focal Hematopoietic Marrow Depositions on MRI: Added Value of Proton Density Fat Fraction.
Jung Y; Jeon SW; Kwack KS; Yun JS; Lee HD; Park S
AJR Am J Roentgenol; 2021 Mar; 216(3):734-741. PubMed ID: 33405947
[No Abstract] [Full Text] [Related]
48. Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
Al-Muqbel KM; Yaghan RJ; Al-Omari MH; Rousan LA; Dagher NM; Al Bashir S
Nucl Med Commun; 2016 Jun; 37(6):593-601. PubMed ID: 26813990
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic accuracy of susceptibility-weighted magnetic resonance imaging for the evaluation of pineal gland calcification.
Adams LC; Böker SM; Bender YY; Diederichs G; Fallenberg EM; Wagner M; Hamm B; Makowski MR
PLoS One; 2017; 12(3):e0172764. PubMed ID: 28278291
[TBL] [Abstract][Full Text] [Related]
50. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
51. Comparison of four MRI protocols for detection of extrahepatic colorectal cancer metastases.
Sivesgaard K; Jöhnk ML; Larsen LP; Sørensen M; Kramer S; Løgager VB; Hansen F; Pedersen EM
J Magn Reson Imaging; 2017 Dec; 46(6):1619-1630. PubMed ID: 28301099
[TBL] [Abstract][Full Text] [Related]
52. Lung cancer screening with MRI: characterization of nodules with different non-enhanced MRI sequences.
Meier-Schroers M; Homsi R; Schild HH; Thomas D
Acta Radiol; 2019 Feb; 60(2):168-176. PubMed ID: 29792040
[TBL] [Abstract][Full Text] [Related]
53. Quantitative Sodium MR Imaging at 7 T: Initial Results and Comparison with Diffusion-weighted Imaging in Patients with Breast Tumors.
Zaric O; Pinker K; Zbyn S; Strasser B; Robinson S; Minarikova L; Gruber S; Farr A; Singer C; Helbich TH; Trattnig S; Bogner W
Radiology; 2016 Jul; 280(1):39-48. PubMed ID: 27007803
[TBL] [Abstract][Full Text] [Related]
54. MR imaging of vertebral metastases at 0.2 Tesla: clinical evaluation of T1-weighted opposed-phase gradient-echo imaging.
Ohno S; Togami I; Sei T; Ida K; Tsunoda M; Yamaoka K; Kanazawa S; Hiraki Y
Physiol Chem Phys Med NMR; 2003; 35(2):145-56. PubMed ID: 15552725
[TBL] [Abstract][Full Text] [Related]
55. Hematopoietic islands mimicking osteoblastic metastases within the axial skeleton.
Goller SS; Erber B; Fink N; Dürr HR; Knösel T; Ricke J; Baur-Melnyk A
BMC Musculoskelet Disord; 2022 May; 23(1):448. PubMed ID: 35550061
[TBL] [Abstract][Full Text] [Related]
56. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN
J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
[TBL] [Abstract][Full Text] [Related]
57. [The value of imaging techniques for bone metastases].
Kratochwil C
Urologe A; 2007 Aug; 46(8):891-6. PubMed ID: 17653687
[TBL] [Abstract][Full Text] [Related]
58. [Clinical imaging of osteo-condensed metastases].
Buthiau D; Antoine EC; Lapresle P; Wechsler B; Missenard G; Misset JL; Denarnaud J; Khayat D; Ziza JM
Rev Med Interne; 1999 Apr; 20(4):353-64. PubMed ID: 10327481
[TBL] [Abstract][Full Text] [Related]
59. Preconditioned water-fat total field inversion: Application to spine quantitative susceptibility mapping.
Boehm C; Sollmann N; Meineke J; Ruschke S; Dieckmeyer M; Weiss K; Zimmer C; Makowski MR; Baum T; Karampinos DC
Magn Reson Med; 2022 Jan; 87(1):417-430. PubMed ID: 34255370
[TBL] [Abstract][Full Text] [Related]
60. Can Susceptibility-weighted MRI Help Differentiate Osteolytic from Osteoblastic Spine Metastases?
Schweitzer ME
Radiology; 2019 Jan; 290(1):155-156. PubMed ID: 30375933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
